Get the Stockscreener App
2.58
2.79%
0.07
After Hours:
2.58
Seastar Medical Holding Corp stock is traded at $2.58, with a volume of 76,829.
It is up +2.79% in the last 24 hours and up +7.05% over the past month.
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
See More
Previous Close:
$2.51
Open:
$2.54
24h Volume:
76,829
Relative Volume:
0.64
Market Cap:
$9.80M
Revenue:
-
Net Income/Loss:
$-26.23M
P/E Ratio:
-2.102
EPS:
-1.2274
Net Cash Flow:
$-10.29M
1W Performance:
-5.84%
1M Performance:
+7.05%
6M Performance:
-67.54%
1Y Performance:
-84.91%
1-Day Range:
$2.54
$2.71
1-Week Range:
$2.475
$2.885
52-Week Range:
$2.20
$25.70
Seastar Medical Holding Corp Stock (ICU) Company Profile
Name
Seastar Medical Holding Corp
Sector
Industry
Phone
844-427-8100
Address
3513 BRIGHTON BLVD, DENVER
Compare ICU vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICU
Seastar Medical Holding Corp
|
2.58 | 9.54M | 0 | -26.23M | -10.29M | -1.2274 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Seastar Medical Holding Corp Stock (ICU) Latest News
50 children enrolled in FDA safety registry for sepsis kidney therapy - Stock Titan
Short Interest in SeaStar Medical Holding Corporation (NASDAQ:ICU) Rises By 85.5% - Defense World
SeaStar Medical (NASDAQ:ICU) vs. Organon & Co. (NYSE:OGN) Financial Contrast - Defense World
Is SeaStar Medical Holding Corporation likely to announce a buybackQuarterly Trade Report & Stepwise Trade Signal Guides - mfd.ru
ICU Should I Buy - Intellectia AI
Aug Weekly: Will SeaStar Medical Holding Corporation stock recover after earningsTrade Volume Report & Growth-Oriented Investment Plans - baoquankhu1.vn
ICU Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
What are SeaStar Medical Holding Corporation’s earnings expectationsGap Up & AI Forecasted Entry/Exit Points - mfd.ru
SeaStar Medical Holding Co. (NASDAQ:ICUCW) Short Interest Down 12.5% in January - Defense World
How SeaStar Medical Holding Corporation Equity Warrant stock trades before earnings2025 Big Picture & Weekly Momentum Stock Picks - mfd.ru
Can SeaStar Medical Holding Corporation Equity Warrant stock reach $100 price target2025 Buyback Activity & Safe Investment Capital Preservation Plans - mfd.ru
Investors report 9.99% SeaStar Medical (ICU) ownership via warrants - Stock Titan
SeaStar Medical price target lowered to $6 from $10 at Maxim - TipRanks
ICU: Publication Validates Real-World Clinical Impact of QUELIMMUNE in Pediatric AKI - Smartkarma
ICU News Today | Why did SeaStar Medical stock go up today? $ICU - MarketBeat
Published on: 2026-02-11 10:56:42 - mfd.ru
Director Kenneth Van Heel awarded 3,000 RSUs at SeaStar Medical (ICU) - Stock Titan
SeaStar Medical reports strong survival data for QUELIMMUNE therapy By Investing.com - Investing.com Australia
SeaStar Medical stock falls after publishing pediatric therapy data - Investing.com Nigeria
SeaStar Medical stock falls after publishing pediatric therapy data By Investing.com - Investing.com India
SeaStar Medical reports ‘strong’ survival data in Quelimmune study - TipRanks
SeaStar Medical reports strong survival data for QUELIMMUNE therapy - Investing.com
SeaStar Medical Reports Positive 90-Day Survival Data for QUELIMMUNE Therapy in Pediatric Patients with Acute Kidney Injury - Quiver Quantitative
SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI) - The Manila Times
SeaStar Medical Announces Publication in Pediatric - GlobeNewswire
Energy Moves: Can SeaStar Medical Holding Corporation be the next market leaderJuly 2025 Institutional & Stepwise Trade Execution Plans - baoquankhu1.vn
Is SeaStar Medical Holding Corporation Equity Warrant stock undervalued vs historical averagesWeekly Profit Report & Long-Term Capital Growth Strategies - mfd.ru
SeaStar Medical (NASDAQ:ICU) and Danaher (NYSE:DHR) Financial Review - Defense World
Wall Street Recap: Is SeaStar Medical Holding Corporation Equity Warrant still a buy after recent gainsJuly 2025 WrapUp & Consistent Profit Trade Alerts - baoquankhu1.vn
CEO Chat with Eric Schlorff, CEO of SeaStar Medical Holding Corporation - Yahoo Finance
Fed Meeting: Will SeaStar Medical Holding Corporation Equity Warrant stock benefit from M A - baoquankhu1.vn
Is SeaStar Medical Holding Corporation Equity Warrant currently under institutional pressureInflation Watch & Safe Entry Momentum Tips - mfd.ru
SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference - Yahoo Finance
Market Trends: What are SeaStar Medical Holding Corporations earnings expectationsQuarterly Market Summary & High Win Rate Trade Alerts - baoquankhu1.vn
Is SeaStar Medical Holding Corporation Equity Warrant still a buy after recent gainsJuly 2025 Final Week & High Conviction Investment Ideas - mfd.ru
Zacks Small Cap Estimates SeaStar Medical FY2025 Earnings - Defense World
Merger Talk: Will SeaStar Medical Holding Corporation Equity Warrant benefit from rate cuts2025 Buyback Activity & Accurate Trade Setup Notifications - baoquankhu1.vn
Levels Update: Can SeaStar Medical Holding Corporation Equity Warrant reach all time highs this yearJuly 2025 Market Mood & Daily Technical Stock Forecast Reports - baoquankhu1.vn
SeaStar Medical Holding (ICU) Price Target Increased by 900.00% to 10.20 - Nasdaq
Is SeaStar Medical Holding Corporation stock attractive for income investorsJuly 2025 Levels & Safe Swing Trade Setups - ulpravda.ru
SeaStar Medical Holding CorporationWarrant (Nasdaq:ICUCW) Stock Quote - The Chronicle-Journal
Does SeaStar Medical Holding Corporation Equity Warrant stock trade at a discount to peers2025 Big Picture & Fast Moving Stock Watchlists - Улправда
Can SeaStar Medical Holding Corporation Equity Warrant stock attract ESG capital inflows - Улправда
Will SeaStar Medical Holding Corporation Equity Warrant stock outperform value stocks2025 AllTime Highs & Real-Time Chart Pattern Alerts - Улправда
Will SeaStar Medical Holding Corporation Equity Warrant stock keep outperforming rivalsTrade Exit Report & Fast Exit/Entry Strategy Plans - Улправда
How SeaStar Medical Holding Corporation Equity Warrant stock reacts to Fed rate cutsStop Loss Placement Tips & Turn Bull Runs into Life-Changing Wealth - Улправда
SeaStar Medical announces 2026 milestones - TipRanks
SeaStar Medical Announces 2026 Milestones - The Manila Times
SeaStar Medical Holding Corp Share Price USD0.0001 (POST CON) - Hargreaves Lansdown
SeaStar Medical to Present at Biotech Showcase 2026 Investor Conference and Engage with Investors at J.P. Morgan Healthcare Conference | ICU Stock News - Quiver Quantitative
SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference - marketscreener.com
Seastar Medical Holding Corp Stock (ICU) Financials Data
Revenue
Net Income
Cash Flow
EPS
Seastar Medical Holding Corp Stock (ICU) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Messinger Michael | Chief Financial Officer |
Dec 09 '25 |
Buy |
0.35 |
14,500 |
5,098 |
17,500 |
| Van Heel Kenneth | Director |
Aug 26 '25 |
Buy |
0.89 |
25,000 |
22,248 |
39,400 |
| Van Heel Kenneth | Director |
Aug 27 '25 |
Buy |
0.86 |
10,000 |
8,565 |
49,400 |
| Chung Kevin | Chief Medical Officer |
Aug 22 '25 |
Buy |
0.80 |
10,000 |
8,000 |
58,184 |
| Neuman John | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
2,667 |
0 |
88,000 |
| Vincent Bernadette N | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
2,667 |
0 |
8,000 |
| Van Heel Kenneth | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
4,000 |
0 |
10,400 |
| Chung Kevin | Chief Medical Officer |
Jul 01 '25 |
Option Exercise |
0.00 |
5,000 |
0 |
48,184 |
| Schlorff Eric | Chief Executive Officer |
Jul 01 '25 |
Option Exercise |
0.00 |
21,667 |
0 |
98,517 |
| Baird Jennifer A | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
2,667 |
0 |
18,000 |
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):